Cabazitaxel
Cabazitaxel has been studied in 1 paper since 2026: 1 trial in people; 1 in the past year. The newest paper, Feb 6, 2026: “Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer”.
See all 1 papers on cabazitaxel
At a glance
4 trials, none about aging.
Cells, worms or flies, mice and humans: nothing yet.
- 4 trials, none about aging
- Human trial1
Trial sponsors
Company1 trialPhase 230 people
Company1 trialPhase 1/2220 people
Janssen Research & Development
Company1 trialPhase 1300 people
Alliance for Clinical Trials in Oncology
1 trialPhase 2474 people
Latest
1 paper in 12 monthsClinical Cancer Research
Clonal Hematopoiesis after 177Lu-PSMA-617 Radioligand Therapy in Prostate Cancer
Randomized trial in 178 peopleBlood and immune system